10.1016/j.bbadis.2017.08.026 Biochim Biophys Acta - Mol Basis Dis
Kurabayashi et al
Yilmaz M, Muftuoglu M, Kantarjian H, DiNardo CD, Kadia TM, Konopleva M, Borthakur G, Pemmaraju N, Short NJ, Alvarado Y, Maiti A, Masarova L, Montalban-Bravo G, Jurisprudencia C, Pike AM, Loghavi S, Patel K, Tang G, Matthews JA, Kornblau SM, Jabbour EJ, MD, Garcia-Manero G, Ruvolo V, Ravandi F, Andreeff M , Daver N
NAFLD could be considered an hepatic manifestation of metabolic syndrome, given the strong association with obesity, type 2 diabetes, hypertension and dyslipidaemia (3)
Nick GL
Incomplete Dissolution Problem: The powder doesn't fully dissolve, leaving visible particles or a cloudy solution, even after gentle swirling